- Home
- ANL vs DOMH Comparison
ANL vs DOMH Comparison
Compare ANL & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- DOMH
- Stock Information
- Founded
- ANL 2004
- DOMH 1967
- Country
- ANL Cayman Islands
- DOMH United States
- Employees
- ANL N/A
- DOMH N/A
- Industry
- ANL
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- ANL
- DOMH Health Care
- Exchange
- ANL Nasdaq
- DOMH Nasdaq
- Market Cap
- ANL 62.4M
- DOMH 74.7M
- IPO Year
- ANL 2023
- DOMH N/A
- Fundamental
- Price
- ANL $1.68
- DOMH $6.48
- Analyst Decision
- ANL Hold
- DOMH
- Analyst Count
- ANL 1
- DOMH 0
- Target Price
- ANL N/A
- DOMH N/A
- AVG Volume (30 Days)
- ANL 9.0K
- DOMH 435.3K
- Earning Date
- ANL 09-02-2025
- DOMH 08-11-2025
- Dividend Yield
- ANL N/A
- DOMH 5.04%
- EPS Growth
- ANL N/A
- DOMH N/A
- EPS
- ANL N/A
- DOMH N/A
- Revenue
- ANL N/A
- DOMH $52,811,000.00
- Revenue This Year
- ANL N/A
- DOMH N/A
- Revenue Next Year
- ANL N/A
- DOMH N/A
- P/E Ratio
- ANL N/A
- DOMH N/A
- Revenue Growth
- ANL N/A
- DOMH 455.38
- 52 Week Low
- ANL $1.10
- DOMH $0.83
- 52 Week High
- ANL $3.89
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- ANL 55.77
- DOMH 59.69
- Support Level
- ANL $1.50
- DOMH $5.23
- Resistance Level
- ANL $1.99
- DOMH $6.91
- Average True Range (ATR)
- ANL 0.15
- DOMH 0.66
- MACD
- ANL 0.01
- DOMH 0.02
- Stochastic Oscillator
- ANL 43.82
- DOMH 56.08
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.